FGF23 and hypophosphatemia: Pharmacological management includes vitamin D repletion (according to specific guidelines), phosphate supplementation, use of active vitamin D analogue if FGF-23 mediated hypophosphatemia is present, and treatment of associated hyperfunctioning endocrinopathies accordingly ( 5 ).